aims: Under suboptimal storage and transport conditions, influenza virus (flu-v) RNA is prone to degradation and lysis buffers from RNA extraction kits have a potential to stabilize RNA. The aim of this study was to investigate the effects of different lysis buffers on the stability of flu-v RNA. Materials & methods: Aliquots of flu-v suspension were processed in parallel with two lysis buffers, and then underwent cyclic freeze-thaw or prolonged storage at 4, 22 and -20°C. The viral RNA was analyzed by using real-time and conventional RT-PCR amplifying, respectively, partial and full-length sequences of the flu-v matrix gene. Results: The viral RNA remained intact in samples treated with either of the two lysis buffers for at least 7 days at 4°C, 90 days at -20°C or following seven freeze-thaw cycles, but buffer A was superior to buffer B in protecting RNA from degradation at 4°C and 22°C, or following a further increase of freeze-thaw cycles. conclusion: Lysis buffer preservatives provide viral RNA stabilization, whereas different lysis buffers vary in their ability to stabilize viral RNA, and thus their performance characteristics should be evaluated prior to their application in clinical practice.
KeywordsNucleic acid (NA)-based techniques are now widely used in influenza surveillance and diagnosis [1,2]. However, suboptimal storage and transport conditions of influenza virus (flu-v) samples will most likely result in viral RNA degradation [3][4][5], and in some settings it is difficult to ensure certain sample conditions required by WHO, such as ultra-low-temperature freezing, especially for resource-limited areas; consequently, the efficacy of the NA-based assays will be compromised. Thus, inexpensive, simple and efficient sample stabilization methods need to be developed for facilitating flu surveillance and diagnosis.Earlier studies have shown that lysis buffers of NA extraction kits have the potential to be used as RNA stabilization agents at adverse temperatures and over an extended period of time [6,7], and have potential to inactivate viruses completely [8], which would reduce the biohazard risk from sample leakage during transit and simplify transportation requirements while preserving the integrity of viral RNA before testing. Nevertheless, these studies did not give a comprehensive picture of the abilities of lysis buffers in protecting viral RNA from degradation and there are still some questions that remain unanswered. First, could intact viral RNA be recovered from the samples preserved in lysis buffer at adverse temperatures and over an extended period of time, considering that a real-time RT-PCR (rRT-PCR) targeting a shorter fragment was only employed to evaluate the presence, quantity and/or quality of viral RNA in these studies [6,7]? Second, what is the consequence of virus samples preserved in lysis buffer and subjected to repeated freeze-thaw cycles, For reprint orders, please contact: reprints@futuremedicine.com